Clinical trial
Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence
NCT00032929 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind, Placebo-Controlled Trial of Selegiline Transdermal System for the Treatment of Cocaine Dependence
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- March 31, 2001
- Completion date
- Not reported
- Enrollment
- 269 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.